Tagged

Schizophrenia Treatment

Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.

Editorial still-life of a small unbranded plain glass medical vial with a smooth metallic crimp top standing upright on a quiet pale clinical countertop representing a long-acting injectable antipsychotic formulation, a small unbranded plain disposable syringe with a sheathed needle resting flat horizontally beside the vial representing the injection itself, a small shallow round amber-tinted glass dish to the side holding three small smooth round white tablets representing the tapering oral antipsychotic overlap, a small simple sealed brushed-metal sharps container in the background representing safe injection practice, and a small ruled cream paper notepad in the foreground with a thin black fountain pen resting diagonally across it representing the PMHNP transition protocol notes — header illustration for a 2026 PMHNP clinical-practice guide on switching patients from oral antipsychotics to long-acting injectables.

Clinical Practice

LAI Antipsychotics: 2026 PMHNP Transition Protocol

PMHNP step-by-step protocol for switching oral antipsychotics to long-acting injectables in 2026: aripiprazole, paliperidone, risperidone overlap.

June 2, 2026 Read More →

Editorial still-life of a small ceramic anatomical brain sculpture with two softly glowing accent points suggesting two distinct receptor targets, a small unlabeled amber medicine bottle with a few capsules beside it, an upright fountain pen across a closed manila folder, and a ceramic mug of herbal tea with gentle steam on a quiet wooden desk in soft natural side light — header illustration for a 2026 PMHNP prescribing guide to Cobenfy (xanomeline-trospium), the first new-mechanism antipsychotic for schizophrenia in decades.

Clinical Practice

Cobenfy for Schizophrenia: A 2026 PMHNP Prescribing Guide

Cobenfy is the first schizophrenia drug that skips D2 blockade entirely. Here is how PMHNPs dose, titrate, and monitor xanomeline-trospium safely in 2026.

May 15, 2026 Read More →

Schizophrenia Treatment

LAI Antipsychotics: 2026 PMHNP Transition Protocol

Cobenfy for Schizophrenia: A 2026 PMHNP Prescribing Guide

Join the Fellowship today.